108 related articles for article (PubMed ID: 16764881)
1. Elevated platelet P-selectin expression and platelet activation in high risk patients with uncontrolled severe hypertension.
Preston RA; Coffey JO; Materson BJ; Ledford M; Alonso AB
Atherosclerosis; 2007 May; 192(1):148-54. PubMed ID: 16764881
[TBL] [Abstract][Full Text] [Related]
2. Relationship of homocysteine to markers of platelet and endothelial activation in "high risk" hypertensives: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial.
Spencer CG; Martin SC; Felmeden DC; Blann AD; Beevers GD; Lip GY
Int J Cardiol; 2004 Apr; 94(2-3):293-300. PubMed ID: 15093996
[TBL] [Abstract][Full Text] [Related]
3. Enhanced levels of tissue-type plasminogen activator in borderline hypertension.
Wall U; Jern C; Bergbrant A; Jern S
Hypertension; 1995 Nov; 26(5):796-800. PubMed ID: 7591020
[TBL] [Abstract][Full Text] [Related]
4. Circadian pattern of ambulatory blood pressure in hypertensive patients with and without type 2 diabetes.
Ayala DE; Moyá A; Crespo JJ; Castiñeira C; Domínguez-Sardiña M; Gomara S; Sineiro E; Mojón A; Fontao MJ; Hermida RC;
Chronobiol Int; 2013 Mar; 30(1-2):99-115. PubMed ID: 23098178
[TBL] [Abstract][Full Text] [Related]
5. Effects of aspirin on intra-platelet vascular endothelial growth factor, angiopoietin-1, and p-selectin levels in hypertensive patients.
Nadar S; Blann AD; Lip GY
Am J Hypertens; 2006 Sep; 19(9):970-7; discussion 978. PubMed ID: 16942942
[TBL] [Abstract][Full Text] [Related]
6. Platelet activation: a link between psoriasis per se and subclinical atherosclerosis--a case-control study.
Saleh HM; Attia EA; Onsy AM; Saad AA; Abd Ellah MM
Br J Dermatol; 2013 Jul; 169(1):68-75. PubMed ID: 23448140
[TBL] [Abstract][Full Text] [Related]
7. Fibrinolytic activity and platelet release reaction in essential hypertension.
Keskin A; Tombuloglu M; Büyükkeçeci F
Jpn Heart J; 1994 Nov; 35(6):757-63. PubMed ID: 7897822
[TBL] [Abstract][Full Text] [Related]
8. The relationship among TAFI, t-PA, PAI-1 and F1 + 2 in type 2 diabetic patients with normoalbuminuria and microalbuminuria.
Chudý P; Kotuličová D; Staško J; Kubisz P
Blood Coagul Fibrinolysis; 2011 Sep; 22(6):493-8. PubMed ID: 21519232
[TBL] [Abstract][Full Text] [Related]
9. sP-selectin plasma levels in obesity: association with insulin resistance and related metabolic and prothrombotic factors.
De Pergola G; Pannacciulli N; Coviello M; Scarangella A; Di Roma P; Caringella M; Venneri MT; Quaranta M; Giorgino R
Nutr Metab Cardiovasc Dis; 2008 Mar; 18(3):227-32. PubMed ID: 17400434
[TBL] [Abstract][Full Text] [Related]
10. Effect of fluvastatin and valsartan, alone and in combination, on postprandial vascular inflammation and fibrinolytic activity in patients with essential hypertension.
Liu L; Zhao SP; Zhou HN; Li QZ; Li JX
J Cardiovasc Pharmacol; 2007 Jul; 50(1):50-5. PubMed ID: 17666915
[TBL] [Abstract][Full Text] [Related]
11. Assessment of mean platelet volume and soluble CD40 ligand levels in patients with non-dipper hypertension, dippers and normotensives.
Surgit O; Erturk M; Akgul O; Pusuroglu H; Korkmaz AF; Isiksacan N; Gul M; Uzun F; Ozal E; Eksik A
Clin Exp Hypertens; 2015; 37(1):70-4. PubMed ID: 24866755
[TBL] [Abstract][Full Text] [Related]
12. Association of low-grade inflammation and platelet activation in patients with hypertension with microalbuminuria.
Ferroni P; Guagnano MT; Falco A; Paoletti V; Manigrasso MR; Michetti N; Santilli F; Guadagni F; Basili S; Davì G
Clin Sci (Lond); 2008 Mar; 114(6):449-55. PubMed ID: 17988217
[TBL] [Abstract][Full Text] [Related]
13. Increased platelet activation in young patients with prehypertension.
Yuksel C; Celik T; Demirkol S; Celik M; Bugan B; Iyisoy A; Yaman H
Clin Exp Hypertens; 2011; 33(6):381-7. PubMed ID: 21777150
[TBL] [Abstract][Full Text] [Related]
14. Soluble adhesion molecule P-selectin and endothelial dysfunction in essential hypertension: implications for atherogenesis? A preliminary report.
Lip GY; Blann AD; Zarifis J; Beevers M; Lip PL; Beevers DG
J Hypertens; 1995 Dec; 13(12 Pt 2):1674-8. PubMed ID: 8903631
[TBL] [Abstract][Full Text] [Related]
15. Comparison of ambulatory blood pressure parameters of hypertensive patients with and without chronic kidney disease.
Mojón A; Ayala DE; Piñeiro L; Otero A; Crespo JJ; Moyá A; Bóveda J; de Lis JP; Fernández JR; Hermida RC;
Chronobiol Int; 2013 Mar; 30(1-2):145-58. PubMed ID: 23181690
[TBL] [Abstract][Full Text] [Related]
16. Association between platelet activation and fibrinolysis in acute stroke patients.
Wang J; Li J; Liu Q
Neurosci Lett; 2005 Aug; 384(3):305-9. PubMed ID: 15916851
[TBL] [Abstract][Full Text] [Related]
17. Platelet hyperactivity in hypertensive older patients is controlled by lowering blood pressure.
Riondino S; Pignatelli P; Pulcinelli FM; Lenti L; Di Veroli C; Marigliano V; Gazzaniga PP
J Am Geriatr Soc; 1999 Aug; 47(8):943-7. PubMed ID: 10443854
[TBL] [Abstract][Full Text] [Related]
18. Similar levels of low-grade inflammation and arterial stiffness in masked and white-coat hypertension: comparisons with sustained hypertension and normotension.
Andrikou I; Tsioufis C; Dimitriadis K; Syrseloudis D; Valenti P; Almiroudi M; Lioni L; Tousoulis D; Stefanadis C
Blood Press Monit; 2011 Oct; 16(5):218-23. PubMed ID: 21914984
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of plasma soluble P-selectin and von Willebrand factor as indices of platelet activation and endothelial damage/dysfunction in high-risk patients with hypertension: a sub-study of the Anglo-Scandinavian Cardiac Outcomes Trial.
Varughese GI; Patel JV; Tomson J; Blann AD; Hughes EA; Lip GY
J Intern Med; 2007 Apr; 261(4):384-91. PubMed ID: 17391113
[TBL] [Abstract][Full Text] [Related]
20. [The influence of I/D polymorphism of the angiotensin I converting enzyme (ACE) gene and 4G/5G polymorphism of plasminogen activator inhibitor (PAI-1) gene promoter on the haemostatic system in patients with essential hypertension and dyslipidemia].
Nowakowska A
Ann Acad Med Stetin; 2005; 51(1):95-105. PubMed ID: 16496609
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
